Corteva Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $17.8B+5.3% YoYTTM through 30 Jun 2026
Net Income $1B+11.2% YoYTTM through 30 Jun 2026
Free Cash Flow $629MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| EBITDA Margin | 15.9% |
| Operating Margin | 8.9% |
| Net Margin | 5.7% |
Returns
4.0%ROE
2.4%ROA
4.1%ROIC
Balance Sheet Health
Debt / Equity0.07x
Current Ratio1.52x
Net Debt-$683Mnet cash position
Cash & Equivalents$2.4B
Quality Metrics
Altman Z-Score2.71
Piotroski F-Score7 / 9
FCF Margin3.5%
Rule of 405.3
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $17.4B
Diluted EPS$1.53TTMFY2025: $1.60
Dividend
$0.36Per share, FY20260.45%Yield-7.8%5-yr growth
Capital Allocation
R&D Spend$1.5B
Capex Intensity3.3%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Seed | $9.9B | +4.0% | View detailsFor 2026, Seed volumes are expected to be relatively flat due to a North American shift from corn to soybeans, partially offset by Seed price/mix gains and a $120 million benefit from Seed net royalties. |
| Crop Protection | $7.5B | +2.0% | View detailsFor 2026, the global crop protection industry is expected to improve modestly with volume gains from new products and biologicals more than offsetting ongoing pricing pressure. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.